Batavia Bioservices operates two independent BSL-II/ ML-II GMP facilities for the manufacture of drug substance and/ or drug product:
- The first facility (120 m2) consists of a separate cell culture area and two separate class C production suites and two separate downstream clean rooms. Also, separate media/buffer prep, MCB storage and QC areas are present. The facility is currently equipped to run up to 50 Liter mammalian fermentation processes or 20 Liter microbial fermentation processes.
- The second facility (100 m2) consists of a separate pre-culture area; one Class C production suite and one downstream clean room with separate areas for buffer/ media preparation. The facility is equipped to run up to 100 liter mammalian fermentation processes.
Batavia Bioservices thus provides to its customers the manufacture of Master Cell banks/ Working Cell Banks & Master Virus Seeds/ Working Virus Seeds. The company also offers clinical production and release of proteins, antibodies, vaccines and vectors produced in diverse formats (Stainless steel bioreactors, spinner flasks, shake flasks, etc).